Relay Therapeutics, Inc. (RLAY) Return on equity 2020–2025
Relay Therapeutics, Inc. (RLAY) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-48.8%FY2025 · since FY2020: -6.9% → -48.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.8% | -5.3 pp |
| FY2024 | -43.4% | +2.1 pp |
| FY2023 | -45.5% | -14.9 pp |
| FY2022 | -30.6% | +10.0 pp |
| FY2021 | -40.5% | -33.7 pp |
| FY2020 | -6.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →